Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed3

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT04690335Phase 2Completed
Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine
RSV Infection
StudydirectorStart date: 2020-12-29
NCT04444284Phase 1Completed
Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children
Respiratory Syncytial Virus Infections
StudydirectorStart date: 2020-06-09
NCT04227210Phase 1Completed
Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults
Respiratory Syncytial Virus Infections
StudydirectorStart date: 2020-01-14

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Meissa Vaccines, Inc.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Wisman

Pediatric Research of Charlottesville

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

lanjuan li

Shulan (Hangzhou) Hospital

Moderately Similar
6 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Michael Bell

Accel-West Volusia Pediatrics

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Jeffrey Stewart

Family Medical Associates

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Robert Cohen

Association Clinique et Thérapeutique Infantile du Val de Marne

Moderately Similar
3 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Ruth A. Karron, MD

Johns Hopkins Bloomberg School of Public Health

Moderately Similar
9 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Pui Leung

Quotient Clinical

Moderately Similar
3 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Akshay Vaishnaw, MD PhD

Alnylam Pharmaceuticals

Moderately Similar
3 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

William Simon

New Medical Healthcare

Moderately Similar
2 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Gates MRI

Gates Medical Research Institute

Moderately Similar
11 trials

Shared therapeutic areas:

Respiratory Syncytial Virus Infections
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04690335Phase 2StudyDirector

Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine

RSV Infection
Completed
NCT04444284Phase 1StudyDirector

Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children

Respiratory Syncytial Virus Infections
Completed
NCT04227210Phase 1StudyDirector

Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults

Respiratory Syncytial Virus Infections
Completed

All 3 trials loaded